# The Safety and Efficacy of the Enhanced Recovery After Surgery(ERAS)Applied on Cardiac Surgery With Cardiopulmonary Bypass

Study · id `cardio:ct-nct02479581` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02479581](<https://clinicaltrials.gov/study/NCT02479581>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02479581

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 226 participants.

## Technical summary

Registry record NCT02479581. Randomized; quadruple masking; primary purpose treatment. Start 2015-07 (actual); primary completion 2016-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 226 participants (enrolled count; ClinicalTrials.gov record NCT02479581, source copy `cardio:ctgov-nct02479581-2017-06-01`, retrieved 2026-10-26)
- Started: 2015-07 (actual) (ClinicalTrials.gov record NCT02479581, source copy `cardio:ctgov-nct02479581-2017-06-01`, retrieved 2026-10-26)
- Primary completion: 2016-11 (actual) (ClinicalTrials.gov record NCT02479581, source copy `cardio:ctgov-nct02479581-2017-06-01`, retrieved 2026-10-26)
- Completion: 2017-05 (actual) (ClinicalTrials.gov record NCT02479581, source copy `cardio:ctgov-nct02479581-2017-06-01`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT02479581, source copy `cardio:ctgov-nct02479581-2017-06-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02479581-2017-06-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Safety and Efficacy of the Enhanced Recovery After Surgery(ERAS)Applied on Cardiac Surgery With Cardiopulmonary Bypass
- Acronym: ERAS
- Condition: Valvular Heart Disease
- Intervention (Procedure): ERAS group
- Intervention (Procedure): ERAS group
- Intervention (Procedure): ERAS group
- Intervention (Procedure): ERAS group
- Intervention (Procedure): ERAS group
- Intervention (Procedure): ERAS group
- Intervention (Procedure): ERAS group
- Intervention (Procedure): ERAS group
- Intervention (Procedure): ERAS group
- Intervention (Procedure): ERAS group
- Intervention (Procedure): ERAS group
- Intervention (Procedure): ERAS group
- Intervention (Procedure): Conventional control group
- Intervention (Procedure): ERAS group
- Intervention (Procedure): Conventional control group
- Intervention (Procedure): Conventional control group
- Intervention (Procedure): Conventional control group
- Intervention (Procedure): Conventional control group
- Intervention (Procedure): Conventional control group
- Intervention (Procedure): Conventional control group
- Lead sponsor: Xiangya Hospital of Central South University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Xiangya Hospital of Central South University (`cardio:org-xiangya-hospital-of-central-south-university`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Enhanced recovery after surgery pathway for patients undergoing cardiac surgery: a randomized clinical trial (`cardio:pubmed-29514224`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: a2be67ed8f331f3713c067f5fdb2d1a87245a5bc44377f4c7ae6826a34f7666c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
